CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 130 filers reported holding CASTLE BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $497,444 | +17.3% | 29,452 | -4.7% | 0.00% | – |
| Q2 2023 | $424,141 | -32.8% | 30,914 | +11.2% | 0.00% | -100.0% |
| Q1 2023 | $631,389 | +15.8% | 27,790 | +19.9% | 0.00% | 0.0% |
| Q4 2022 | $545,470 | +31.1% | 23,172 | +45.4% | 0.00% | – |
| Q3 2022 | $416,000 | +20.6% | 15,939 | +1.8% | 0.00% | – |
| Q2 2022 | $345,000 | -48.3% | 15,663 | +5.4% | 0.00% | -100.0% |
| Q1 2022 | $667,000 | +18.3% | 14,864 | +13.0% | 0.00% | – |
| Q4 2021 | $564,000 | -33.7% | 13,158 | +2.9% | 0.00% | – |
| Q3 2021 | $851,000 | -3.2% | 12,793 | +6.7% | 0.00% | – |
| Q2 2021 | $879,000 | +2.0% | 11,995 | -4.7% | 0.00% | – |
| Q1 2021 | $862,000 | +4.7% | 12,584 | +2.6% | 0.00% | – |
| Q4 2020 | $823,000 | +71.8% | 12,270 | +31.7% | 0.00% | – |
| Q3 2020 | $479,000 | – | 9,314 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |